Bisdemethoxycurcumin enhances X-ray-induced apoptosis possibly through p53/Bcl-2 pathway

Mutat Res Genet Toxicol Environ Mutagen. 2017 Mar:815:1-5. doi: 10.1016/j.mrgentox.2016.12.005. Epub 2017 Jan 11.

Abstract

Bisdemethoxycurcumin (BDMC), which is isolated from the rhizomes of Curcuma longa, has anti-inflammatory and anti-carcinogenic activities. Here we found that BDMC enhanced X-ray-induced apoptosis in human T-cell leukemia MOLT-4 cells. Knockdown of p53 significantly attenuated the radiosensitizing effect of BDMC. However, BDMC did not enhance X-ray-mediated activation of the p53 signaling pathway via p53's transactivation or mitochondrial translocation. On the other hand, BDMC promoted the X-ray-induced dephosphorylation at Ser 70 in Bcl-2's flexible loop regulatory domain and Bcl-2 binding to p53. Overexpressing Bcl-2 completely blocked the BDMC's radiosensitization effect. Our results indicate that BDMC stimulates the dephosphorylation and p53-binding activity of Bcl-2 and suggest that BDMC may induce a neutralization of Bcl-2's anti-apoptotic function, thereby enhancing X-ray-induced apoptosis.

Keywords: Bcl-2; Bisdemethoxycurcumin (BDMC); Radiosensitization; p53/Bcl-2 binding.

MeSH terms

  • Apoptosis / drug effects*
  • Apoptosis / radiation effects
  • Cell Line, Tumor
  • Curcumin / analogs & derivatives*
  • Curcumin / pharmacology
  • Diarylheptanoids
  • Humans
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Tumor Suppressor Protein p53 / metabolism*
  • X-Rays

Substances

  • Diarylheptanoids
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • bisdemethoxycurcumin
  • Curcumin